PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.79%
Some net income increase while CFLT is negative at -21.27%. John Neff would see a short-term edge over the struggling competitor.
45.85%
D&A growth well above CFLT's 11.19%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
1.38%
Less SBC growth vs. CFLT's 10.18%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
100.00%
Working capital change of 100.00% while CFLT is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
91.58%
AR growth while CFLT is negative at -491.34%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
82.48%
Inventory growth of 82.48% while CFLT is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-253.69%
Negative yoy AP while CFLT is 520.41%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-100.00%
Negative yoy usage while CFLT is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-41.29%
Negative yoy while CFLT is 76.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
98.78%
Operating cash flow growth at 50-75% of CFLT's 167.71%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
4.33%
Lower CapEx growth vs. CFLT's 35.69%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-4.41%
Both yoy lines negative, with CFLT at -14.99%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
6.70%
Below 50% of CFLT's 55.15%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
6.68%
Lower net investing outflow yoy vs. CFLT's 92.42%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
11.61%
Debt repayment growth of 11.61% while CFLT is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-100.00%
Negative yoy issuance while CFLT is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.